ClinicalTrials.gg
RecruitingNCT07152652Updated Sep 29, 2025

Physiological, Hormonal, and DNA-based Mechanisms of Psychosocial Stress and Therapeutic Effect

An interventional study of Groups 4 health in Well-Being, Psychological and Loneliness, sponsored by University of Helsinki. Recruiting at 1 site in Finland. Open to participants aged 18 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-29.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by University of Helsinki · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
18 Months and older
Sex
All
01

Study summary

The goal of this trial is to learn if the Groups 4 Health (G4H) intervention is effective in supporting student well-being at the University of Helsinki. It will also learn about the factors that may influence the efficacy of the intervention (such as facilitators characteristics, stress physiology and changes in gene expression). The main questions it aims to answer are:

  1. Is the G4H intervention effective and cost-effective in supporting student well-being?
  2. To what extent participants' physiological, hormonal, or molecular characteristics mediate the therapeutic effect of the G4H
  3. To what extent participants' genotype moderates the effect of the G4H
  4. To what extent facilitators' characteristics mediate or moderate the effect of the G4H

Data is collected from both the intervention participants and the facilitators.

The G4H facilitators will:

  • Facilitate the G4H intervention.
  • Fill in questionnaires and provide physiological and molecular measurements before, during, and after the G4H intervention.

The G4H participants will:

  • Participate in the G4H intervention.
  • Fill in questionnaires and provide physiological, hormonal and molecular measurements before, during, and after the G4H intervention.
Read the detailed description

This study is a randomized waitlist-controlled trial for investigating the efficacy and cost-efficacy of Groups 4 Health (G4H) brief psychosocial intervention for loneliness among the students at the University of Helsinki. Furthermore, several biological and psychosocial mechanisms that may exert the effects of psychosocial stress and therapeutic change are studied. In addition to various psychosocial factors, the mechanisms include genetic factors and epigenetic alterations, hypothalamic-pituitary axis (HPA) activity (cortisol), and parasympathetic (heart rate variability) and sympathetic (alpha amylase) function of the autonomic nervous system (ANS).

This trial will investigate:

  1. The efficacy and cost-efficacy of the G4H in a wait-list randomized controlled trial (RCT)
  2. To what extent participants' physiological, hormonal or molecular measures of ANS, cortisol, alpha amylase, and Deoxyribonucleic Acid methylation (DNAm) mediate the therapeutic effect of the G4H.
  3. To what extent participants' genotype moderates the effects of the G4H.
  4. To what extent facilitators' characteristics mediates or moderates the effect of the G4H.

The participants will be randomized to start the G4H immediately after randomization or after the waitlist-period of 19 weeks (7 weeks active G4H + 3 months follow-up). The G4H includes five facilitated group sessions and will be delivered over a 7-week period. Data is collected before, during, and after the intervention, as well as in 1-, 3-, and 12-month follow-ups. The waitlist control group does not provide 12-months follow-up data, as they receive the intervention after the 19 weeks waitlist-period.

METHODS:

The study's outcome measures are described in the outcome measures -section. In addition, the following measures are used to answer the research questions.

Experience Sampling Method (ESM):

ESM is used to measure frequent, real-time assessments of participants self-reported mood, and stress appraisals at multiple times throughout the day. ESM is applied to explore the variation and changes in participants daily subjective well-being and loneliness in concurrence with G4H group facilitators stress appraisals before and after facilitation of G4H sessions. The ESM data will be collected using General Data Protection Regulation compliant experience-sampling software program that runs on smartphones (e.g. m-Path).

The daily ESM protocol consists of a morning and evening prompts in which participants are asked to rate their momentarily affect, and daily satisfaction with life. In the morning prompt, participants are also asked to assess daily physiological correlates such as sleep, amount of caffeine, and alcohol consumption, and exercise during the last 24h.

Intervention participants are also asked to answer questions about momentarily appraisal of social company, and loneliness (see outcome measures). Facilitators' event-based sampling takes place before and after the group facilitation and consists of self-report on the appraisals and experiences related to situation with single items derived from widely used questionnaires.

Experiences related to the pre-group situation are assessed from the facilitators during the intervention with items related to momentarily affect: "When thinking about the upcoming group session I feel: calm; happy; determined; enthusiastic; tired; stressed; worried; anxious" (response options: 0 =not at all - 6 = very much), and expectations: "I have prepared well for the session; I trust in my ability to manage the upcoming group session; I expect the session to go well." (response options: 0 = strongly disagree - 6 = strongly agree). Experiences related to the post-group situation are assessed with items related to the group situation: "I feel that the group session went well; I felt competent in facilitating the session; I was present during the session; It was easy for me to feel compassion towards participants" (response options: 0 = strongly disagree - 6 = strongly agree).

Salivary cortisol and alpha amylase:

Saliva samples with Cortisol Salivette synthetic swabs (Sarsted) are collected for cortisol and alpha-amylase measurements from both the intervention participants (see outcomes) and facilitators. These samples are collected by placing a synthetic swab in mouth for 2 minutes and returning it to a plastic tube thereafter.

The cortisol and alpha-amylase samples are provided by the participating facilitators during the first, third, and last intervention sessions. The sampling times are -45, -10, 45, 90, 110, and 135 minutes from the start of the session (6 samples per session).

Covariates related to the stress measurements:

Information on the following potential covariates related to stress physiology is also collected from the intervention participants and facilitators on the same day as the saliva samples are given: situational stress, sleep, physical activity, smoking, alcohol and coffee consumption, menstrual cycle, medication, chronic illness.

Deoxyribonucleic Acid (DNA) measures:

Omnigene saliva Oragene OG-600 DNA (or equivalent) is used for the DNAm and genotype sampling. Both the intervention participants and the facilitators will provide these samples before and immediately after the intervention.

Autonomic nervous system functioning:

A self-developed bra-integrated solution is used to collect non-medical electrocardiogram (ECG)-signal and accelerometer data from the facilitators. Data is collected by wearing a bra during times, when user regularly would use it, but especially on days when there is activity of G4H study. ECG signal is analysed by time- and frequency-based Hearth rate variability analysis (HRV). Accelerometer data is used to estimate physical activity and used for control high movement effects on HRV. HRV is used to assess daily levels of sympathetic and parasympathetic function of the ANS and to estimate cognitive load effects of facilitating G4H sessions.

Participants' background:

Participants' background information is collected from the intervention participants as potential covariates: gender, birth date, mother tongue, marital status, household composition, residential situation, employment status, education, income, subjective financial situation, subjective health, subjective loneliness, subjective minority status and willingness to participate in the intervention and academic skills (4-item organized studying scale, from Learn -questionnaire).

Facilitators' characteristics:

Information is collected at pre-intervention on the facilitator's background (gender, birth date, marital status, household composition, residential situation, employment status, education, work experience, income, subjective financial situation), and professional (12-item Experiences in Close Relationships Short form) and individual (30-item Extra-Short Five -questionnaire) characteristics.

The facilitators will also answer questionnaires during the intervention on study burnout risk (9-item Study Burnout Inventory, at pre-intervention and last session), perceived stress (10-item Perceived Stress Scale, at pre-intervention, 3rd, and last session), self and other compassion (4-item Process Based Assessment Tool, at pre-intervention, 3rd, and last session), and self-assessed skillfulness, difficulties, and feelings (36-item Therapist Work Involvement Scales, at 3rd and last session) as potential mediators or moderators of the intervention's effectiveness.

SAMPLE SIZE AND ANALYSES:

The minimum sample size is 148 intervention participants. Appropriate statistical methods including linear mixed model analyses will be used to study the effectiveness of the G4H intervention and the mediating and moderating factors. Appropriate imputation methods such as multiple imputation by chained equations will be used if necessary.

Written informed consent is gathered from all participants. The participants who have given their consent have the option to withdraw from the study at any point.

02

Conditions studied

  • Well-Being, Psychological
  • Loneliness

Keywords

  • University Students
  • Group Intervention
  • Mental Health
  • Loneliness
  • Social Isolation
  • Anxiety
  • Depression
  • Social Anxiety
  • Social Cohesion
  • Groups 4 Health
  • Stress system functioning
  • Genetics
  • Epigenetics
  • Experience Sampling Method
  • Stress physiology
03

In context

Psychological Well-Being Unverified

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 148 is above the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

University of Helsinki is the lead sponsor of 133 studies on the registry; 19 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Months and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (age 18 and above)
  • Student in the University of Helsinki, Finland
  • Able to speak/read Finnish, Swedish, or English

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
148 participants (estimated)

Study arms

  • Experimental
    Groups 4 Health Intervention

    This group will receive the G4H intervention immediately after randomization

    Behavioral: Groups 4 health

  • No intervention
    Waitlist Control Group

    This group will receive the G4H intervention after the 19 weeks waitlist period

Interventions

  • BehavioralGroups 4 health

    Groups 4 Health (G4H) at the University of Helsinki is a manualized group intervention for the students that focuses on social connectedness and aims at improving general health and life satisfaction. G4H groups are facilitated by two psychology master's students (or licensed psychologists) carefully trained for the intervention and mentored by experienced clinical psychologists. G4H consists of five 90 minutes sessions that aim to give participants the knowledge and skills they need to effectively manage their social group memberships and identities. Each session contains exercises and discussions described in the G4H workbook that target different aspects of group life identified within the social identity model of identity change and put the Social Identity Approach to Health -model to practice. Students earn 2 European Credit Transfer and Accumulation System (ECTS) credits for completing the intervention.

    Also known as: G4H, Ryhmät kuntoon

06

What researchers measure

Primary outcomes

  1. Loneliness

    Loneliness is measured with the 4 and 8-item short forms of the revised University of California, Los Angeles Loneliness Scale (ULS-4 and ULS-8, response options: 1=never, 2=rarely, 3=sometimes, 4=often, lower score means better outcome).

    Time frame: 1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12 months follow-up

  2. Depression

    Symptoms of depression are assessed with the 9-item Patient Health Questionnaire (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  3. Active group memberships

    Multiple group memberships are assessed with the 4-item Exeter Identity Transition Scale (response options: 1 = strongly disagree, 7 = strongly agree, higher score means better outcome).

    Time frame: 1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12-months follow-up

  4. Mental well-being

    Mental well-being is assessed with the 7-item Short Warwick-Edinburgh Mental Wellbeing Scale (response options: 1=not at all, 2=rarely, 3=occasionally, 4=often, 5=all the time, higher score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  5. General well-being

    General well-being is assessed with the 14-item General Population version of the Clinical Outcomes in Routine Evaluation (response options: 0=not at all, 1=only occasionally, 2=sometimes, 3=often, 4=most of/all of the time, lower score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  6. Anxiety

    Symptoms of anxiety are assessed with the 7-item Generalized Anxiety Disorder Questionnaire (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  7. Social anxiety

    Social anxiety is assessed with the 3-item Mini Social Phobia Inventory (response options: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day, lower score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

Secondary outcomes

  1. Perceived Stress

    Perceived stress is measured with the 10-item Perceived Stress Scale (response options: 0 = never, 1 = almost never, 2=sometimes, 3=fairly often, 4=very often, lower scores means better outcome)

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  2. Self- and other-compassion

    Self- and other-compassion is measured with the 4-item Process Based Assessment Tool (response options: 1=very seldom to 5=very often, higher scores means better outcome)

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  3. Health-related quality of life

    Health-related quality of life is measured with the Euro Quality of Life - 5 dimension - 5 level questionnaire (EQ-5D-5L). The measure has 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) comprising of five statements of which the respondent can choose the option that best describes their situation. Higher score means better outcome. This measure is used to calculate the cost-effectiveness of the interventions.

    Time frame: 1) Before the intervention, 2) immediately after the intervention, 3) three months follow-up

  4. Use of social and health care services

    The use of social and health care services for mental health is measured with a self-report questionnaire (medications, health care appointments, hospitalization, counseling). The use of health care services will be monetarized by using Finnish national unit costs. This measure is used to calculate the cost-effectiveness of the interventions.

    Time frame: 1) Before the intervention, 2) immediately after the intervention, 3) three months follow-up

  5. Time used by facilitators

    The time used for planning, executing, and assessing the G4H sessions is reported by the facilitators. This measure is used to calculate the cost-effectiveness of the interventions.

    Time frame: Immediately after each intervention session, during 8 weeks

  6. Study credits accumulated over one year

    Overall accumulated study credit data is gathered from the University of Helsinki (UH) registries. These data will be used both as measures of effectiveness of the interventions and to account for the confounders in the statistical analyses.

    Time frame: 1 year before the intervention, 1 year after the intervention

  7. Grade point average

    One year grade point average is gathered from the UH registries. These data will be used both as measures of effectiveness of the interventions and to account for the confounders in the statistical analyses.

    Time frame: 1 year before the intervention, 1 year after the intervention

  8. Weighted grade point average

    Weighted grade point average is determined by the grades of each course weighted by the number of credits gained for it.

    Time frame: 1 year before the intervention, 1 year after the intervention

  9. Study burnout risk

    Study burnout risk is measured by the 9-item Study Burnout Inventory (response options: 1=Completely disagree, 2=Disagree, 3=Partly disagree, 4=Partly agree, 5=Agree, 6=Completely agree. Lower score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  10. Sleep quality

    Sleep quality is measured with the Single-Item Sleep Quality Scale (response options: 0=terrible to 10=excellent, higher score means better outcome)

    Time frame: 1) Before the intervention, 2) immediately after the intervention 3) one month follow-up, 4) three months follow-up, 5) 12-months follow-up

  11. Salivary cortisol

    The cortisol awakening profile is used as an index of hypothalamic-pituitary-adrenal axis function reflecting stress physiology. The participants' salivary cortisol profiles are studied relative to awakening times. Atypical awakening profiles indicate poorer outcome.

    Time frame: The participants provide the samples on two consecutive days 1) before the intervention 2) after the intervention, and 3) at 3-months follow-up. The sampling times are 0, 30, 45, and 60 minutes after awakening (4 samples per day).

  12. Salivary alpha-amylase

    The salivary alpha-amylase is used as an index of sympathetic nervous system function reflecting stress physiology. The participants' salivary alpha amylase profiles are studied relative to awakening times. Atypical awakening profiles indicate poorer outcome.

    Time frame: The participants provide the samples on two consecutive days 1) before the intervention 2) after the intervention, and 3) at 3-months follow-up. The sampling times are 0, 30, 45, and 60 minutes after awakening (4 samples per day). The alpha amylase awake

  13. Daily positive and negative affect

    Daily affect is assessed with items of The Positive and Negative Affect Schedule: "To what extent do you currently feel: calm; happy; enthusiastic; tired; stressed; anxious?" (response options: 0 =not at all - 6 = very much).

    Time frame: 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up]

  14. Daily health-related information

    Daily health-related factors are assessed with items adapted from the Finnish Institute of Occupational Health Sleep and Health Information Form. Perceived sleep quality and quantity is assessed with an item "Last night I slept well/ enough". (response options: 0 = strongly disagree - 6 = strongly agree). Use of caffeine, alcohol and nicotine products, and amount of physical activity during the past 24 hours are assessed by reporting usage (yes/ no) or the amounts.

    Time frame: 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up

  15. Daily momentary loneliness

    Daily momentary loneliness, and appraisals related to company are assessed with items "I feel lonely" (response options: 0 =not at all - 6 = very much), and if in company "I enjoy this company" (response options: 0 = strongly disagree - 6 = strongly agree).

    Time frame: 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up

  16. Daily satisfaction with life

    Daily life satisfaction is measured with an item: "How satisfied were you with your life today?" (response options: 0 = not at all satisfied - 6 = very satisfied).

    Time frame: 1) Before the intervention, 2) During the intervention, 3) immediately after the intervention, 4) three months follow-up

Other outcomes

  1. Mood

    Mood is measured with scale from 0 (extremely bad mood) to 7 (extremely good mood)

    Time frame: 1) Before the intervention, 2) During the intervention (week 3), 3) immediately after the intervention, 4) one month follow-up, 5) three months follow-up, 6) 12-months follow-up

  2. Identification with the intervention

    Identification with the intervention group is assessed with the Single-Item Social Identification -measure (response options: 1 = fully disagree, 7 = fully agree, higher score means better outcome).

    Time frame: During intervention (week 3)

  3. Participant adherence

    The number of participants consented vs the number of participants completing the intervention, attendance rate of individual sessions

    Time frame: Immediately after each intervention session, during 8 weeks

  4. Facilitator's fidelity to the manual

    To monitor fidelity to the G4H manual, the facilitators of the G4H groups will complete a short checklist at the end of each session to determine compliance to the protocol.

    Time frame: Immediately after each intervention session, during 8 weeks

  5. Participants' Working alliance

    Participants' experience of working alliance is assessed with the 12-item Working Alliance Inventory Short and Revised (response options: 1 = never, 2 = rarely, 3 = occasionally, 4 = sometimes, 5 = often, 6 = very often, 7 = always, 3 subscales: goal, task, bond, higher score means better outcome)

    Time frame: During intervention (week 3)

  6. Facilitators' Working alliance

    Facilitators' working alliance is assessed with an 18-item version of the Therapist Working Alliance Inventory Short Form (response options: 1 = never, 2 = rarely, 3 = occasionally, 4 = sometimes, 5 = often, 6 = very often, 7 = always, 3 subscales: goal, task, bond, higher score means better outcome)

    Time frame: During intervention (week 3)

  7. Group cohesion

    Group cohesion is measured with the 5-item Group Climate Questionnaire (response options: 0=Not at all, 1=A little bit, 2=Somewhat, 3=Moderately, 4=Quite a bit, 5=A great deal, 6=Extremely, higher score means better outcome).

    Time frame: 1) During intervention (week 3), 2) immediately after the intervention

  8. Completing homework

    The number of homework assignments completed by the participants is inquired in a questionnaire.

    Time frame: Immediately after the intervention

  9. Participants' experiences during the intervention

    A learning diary is used to collect qualitative description of experiences during the intervention.

    Time frame: Immediately after each intervention session, during 8 weeks

  10. Motivation to manage social groups

    Motivation to manage social groups is measured by tailored motivation rulers (response options: 1=not at all to 10=extremely, higher score means better outcome)

    Time frame: 1) Before the intervention, 2) during the intervention (week 3), 3) immediately after the intervention

  11. Treatment motivation

    Treatment motivation is measure by the 16-item Situational Motivation Scale (response options: 1 = corresponds not all, 2 = corresponds very little, 3 = corresponds a little, 4 = corresponds moderately, 5 = corresponds enough, 6 = corresponds a lot, 7 = corresponds exactly, higher score means better outcome)

    Time frame: 1) Before the intervention, 2) during the intervention (week 3)

  12. Social support

    Social support is measured with the 3 item Social Support Questionnaire (response options Number: 0-9 people giving support, Satisfaction in support: 0 = very dissatisfied, 10 = very satisfied, higher score means better outcome).

    Time frame: 1) Before the intervention, 2) immediately after the intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Haslam C, Cruwys T, Chang MX, Bentley SV, Haslam SA, Dingle GA, Jetten J. GROUPS 4 HEALTH reduces loneliness and social anxiety in adults with psychological distress: Findings from a randomized controlled trial. J Consult Clin Psychol. 2019 Sep;87(9):787-801. doi: 10.1037/ccp0000427. PubMed 31403815 ↗
  • Haslam C, Cruwys T, Haslam SA, Dingle G, Chang MX. Groups 4 Health: Evidence that a social-identity intervention that builds and strengthens social group membership improves mental health. J Affect Disord. 2016 Apr;194:188-95. doi: 10.1016/j.jad.2016.01.010. Epub 2016 Jan 21. PubMed 26828756 ↗
  • Haslam C, Holme A, Haslam SA, Iyer A, Jetten J, Williams WH. Maintaining group memberships: social identity continuity predicts well-being after stroke. Neuropsychol Rehabil. 2008 Oct-Dec;18(5-6):671-91. doi: 10.1080/09602010701643449. PubMed 18924001 ↗
  • Cruwys T, Haslam C, Rathbone JA, Williams E, Haslam SA, Walter ZC. Groups 4 Health versus cognitive-behavioural therapy for depression and loneliness in young people: randomised phase 3 non-inferiority trial with 12-month follow-up. Br J Psychiatry. 2022 Mar;220(3):140-147. doi: 10.1192/bjp.2021.128. PubMed 35049477 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2028, 39 months after the start.

Of 1,259 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 39 months is above that.

Counting every sponsor, half of 1,302 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2025
First posted
Sep 3, 2025
StartActual
Sep 12, 2025
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Sep 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07152652
Collaborators
Strategic Research Council, Finland, University of Eastern Finland, Finnish Institute for Health and Welfare, Finnish Cultural Foundation
Responsible party
Jari Lahti (Professor, University of Helsinki) — Principal investigator
First posted
Sep 3, 2025
Start date
Sep 12, 2025
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Sep 29, 2025

Study contacts

Jari Lahti, PhD
Contact
jari.lahti@helsinki.fi
040 571 2297 ext. +358

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion